Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING OF TQG203 “RECOMBINANT HUMAN COAGULATION FACTOR VIIa FOR INJECTION” FILED AND ACCEPTED2023.12.13
-
VOLUNTARY ANNOUNCEMENT2023.12.13
-
VOLUNTARY ANNOUNCEMENT2023.12.12
-
VOLUNTARY ANNOUNCEMENT - SINO BIOPHARMACEUTICAL S&P ESG RATING GETS ANOTHER UPGRADE RANKING TOP 9% IN THE GLOBE2023.12.11
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.12.08
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.12.07
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.12.06
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.12.05